Skip to content
Washington University School of Medicine in St. Louis

Hospital Medicine Virtual Journal Club

Menu
  • About
  • Archives
  • FAQs
  • How to Access Full-text Articles
  • How to Use
  • Privacy Policy and Terms of Use

Category: Eur J Gastroenterol Hepatol

Clinical predictors and impact of bacteremia in cirrhotic patients with acute skin and skin structure infection.

Eur J Gastroenterol Hepatol • August 30, 2019

Acute pancreatitis in end-stage renal disease patients in the USA: a nationwide, propensity score-matched analysis.

Eur J Gastroenterol Hepatol • May 29, 2019

Higher odds of irritable bowel syndrome among hospitalized patients using cannabis: a propensity-matched analysis.

Eur J Gastroenterol Hepatol • February 27, 2019

Prognostic value of international normalized ratio to albumin ratio among critically ill patients with cirrhosis.

Eur J Gastroenterol Hepatol • January 3, 2019

Red blood cell distribution width independently predicts 1-month mortality in acute decompensation of cirrhotic patients admitted to emergency department.

Eur J Gastroenterol Hepatol • July 17, 2018

Sickle cell disease is associated with higher mortality among patients hospitalized with ischemic bowel disease.

Eur J Gastroenterol Hepatol • June 30, 2018

Clostridium difficile co-infection in inflammatory bowel disease is associated with significantly increased in-hospital mortality.

Eur J Gastroenterol Hepatol • June 13, 2018

Home-based drainage of refractory ascites by a permanent-tunneled peritoneal catheter can safely replace large-volume paracentesis.

Eur J Gastroenterol Hepatol • October 11, 2017

Emergency readmission following acute upper gastrointestinal bleeding.

Eur J Gastroenterol Hepatol • July 25, 2017

Intestinal cytomegalovirus infection in patients hospitalized for exacerbation of inflammatory bowel disease: a 10-year tertiary referral center experience.

Eur J Gastroenterol Hepatol • February 24, 2016

Follow Us!

Follow Us on FacebookFollow Us on TwitterFollow Us on Instagram

Journal Club via Email

The HMVJC Minute Podcast

Subscribe Now!
  • AnchorAnchor
  • Apple PodcastsApple Podcasts
  • BreakerBreaker
  • Google PodcastsGoogle Podcasts
  • iHeartRadioiHeartRadio
  • PocketCastsPocketCasts
  • PodbayPodbay
  • Radio PublicRadio Public
  • SpotifySpotify
  • TikTokTikTok
  • YouTubeYouTube

Recent Comments

  • Anonymous on Things We Do for No Reason™: Obtaining Urine Testing in Older Adults With Delirium Without Signs or Symptoms of Urinary Tract Infection
  • agario unblocked on Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021
  • Ronald M. Chavin on What about tocilizumab? A retrospective study from a NYC Hospital during the COVID-19 outbreak
  • An Examination of Ivermectin and Other Promising Medications in the Prevention and Treatment of COVID | Compounding Corner Pharmacy, Inc. on Montelukast in Hospitalized Patients Diagnosed with COVID-19
  • Nathan Martin on Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19: The ACTIV-4B Randomized Clinical Trial

The HMVJC COVID Reading List

  • Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
  • Efficacy and Safety of Intensified Versus Standard Prophylactic Anticoagulation Therapy in Patients With Coronavirus Disease 2019: A Systematic Review and Meta-Analysis
  • Elevated D-dimer and Adverse In-hospital Outcomes in COVID-19 Patients and Synergism with Hyperglycemia
  • Occurrence and outcomes of possible superadded infections in older adults with COVID-19-cohort study
  • Comparison of the effect of intravenous dexamethasone and methylprednisolone on the treatment of hospitalized patients with COVID-19: A randomized clinical trial
  • Tixagevimab-cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial
  • Re-examining the widespread policy of stopping SGLT2 inhibitors during acute illness: A perspective based on the updated evidence
  • Tocilizumab Versus Baricitinib in Patients Hospitalized With COVID-19 Pneumonia and Hypoxemia: A Multicenter Retrospective Cohort Study
  • Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized with COVID-19: A Blinded Randomized Placebo-Controlled Trial
  • Ivermectin for preventing and treating COVID-19

Links

  • WU School of Medicine
  • Dept. of Medicine
  • Division of Hospital Medicine
  • Becker Medical Library
  • Society of Hospital Medicine
  • Today's Hospitalist

Editor: Robert J. Mahoney, M.D., CCS-P, SFHM

Powered by
PubMed

©2022 Washington University in St. Louis